Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 309

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Open access
Rovin, Brad H., Solomons, Neil, Pendergraft, William F., Dooley, Mary Anne, Tumlin, James, Romero-Diaz, Juanita, Lysenko, Lidia, Navarra, Sandra V., Huizinga, Robert B., Adzerikho, Ihar, Mikhailova, Elena, Mitkovskaya, Natalya, Pimanov, Sergey, Soroka, Nikolay, Bogov, Boris Iliev, Deliyska, Boriana, Ikonomov, Valentin, Tilkiyan, Eduard, Almeida, Ruth, Jimenez, Fernando, Teran, Faud, Tchokhonelidze, Irma, Tsiskarishvili, Nino, Herrera Mendez, Maynor, Chavez Perez, Nilmo Noel, Loaeza, Arturo Reyes, Gutierrez Urena, Sergio Ramon, Romero Diaz, Juanita, Araiza Casillas, Rodolfo, Madero Rovalo, Magdalena, Niemczyk, Stanislaw, Sokalski, Antoni, Wiecek, Andrzej, Klinger, Marian, Bugrova, Olga V., Chernykh, Tatiana M., Kameneva, Tatiana R., Lysenko, Lidia V., Raskina, Tatiana A., ReshEtko, Olga V., Vezikova, Natalia N., Kropotina, Tatiana V., Maksudova, Adelya N., Marasaev, Vyacheslav, Dobronravov, Vladimir A., Gordeev, Ivan, EssAian, Ashot M., Frolov, Alexey, Jelacic, Rosa, Jovanovic, Dragan, Mitic, Branka, Pekovic, Gordana, Radovic, Milan, Radunovic, Goran, Carreira, Patricia, Diaz Gonzalez, Federico, Fulladosa, Xavier, Ucar, Eduardo, De Silva, Shamila, Herath, Chula, Hewageegana, Anura, Nazar, Abdul Latiff Mohamed, Wazil, A.W.M., Dudar, Iryna, Godlevska, Olga, Korneyeva, Svitlana, Vasylets, ViktoriIa, Sydor, Nataliya, Kolesnyk, Mykola, Parikh, Samir V., Olsen, Nancy, Ginzler, Ellen M., Tumlin, James A., Saxena, Amit, Saxena, Ramesh, Lafayette, Richard Alan, Pendergraft, William Franklin, Podoll, Amber S., Arrey-Mensah, Annie A., Bubb, Michael, Grossman, Jennifer, Oporta, Alejandro I., Nami, Alireza, Rahman, Md. Mujibur, Haq, Syed Atiqul, Chan, Tak Mao Daniel, Temy, Mok Mo Yin, Gomez, Harold Michael P., Bermas, James, Reyes, Bernadette Heizel, Hao, Llewellyn T., Roberto, Linda Charmaine, Amante, Eric, Navarra, Sandra V., Lanzon, Allan E., Choe, Jung-Yoon, Kang, Tae Young, Kim, Yon Su, Lee, Seung-Geun, Lee, Ji Soo, Jun, Jason Choo Chon, Vasudevan, Archana, Luo, Shue-Fen, Cheng, Tien-Tsai, Satirapoj, Bancha, Noppakun, Kajohnsak · 2019 · Kidney International

Abstract

Calcineurin inhibitors added to standard-of-care induction therapy for lupus nephritis (LN) may increase complete renal remission (CRR) rates. The AURA-LV study tested the novel calcineurin inhibitor voclosporin for efficacy and safety in active LN. AURA-LV was a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial of two doses of voclosporin (23.7 mg or 39.5 mg, each twice daily) versus placebo in combination with mycophenolate mofetil (2 g/d) and rapidly tapered low-dose oral corticosteroids for induction of remission in LN. The primary endpoint was CRR at 24 weeks; the secondary endpoint was CRR at 48 weeks. Two hundred sixty-five subjects from 79 centers in 20 countries were recruited and randomized to treatment for 48 weeks. CRR at week 24 was achieved by 29 (32.6%) subjects in the low-dose voclosporin group, 24 (27.3%) subjects in the high-dose voclosporin group, and 17 (19.3%) subjects in the placebo group (OR=2.03 for low-dose voclosporin versus placebo). The significantly greater CRR rate in the low-dose voclosporin group persisted at 48 weeks, and CRRs were also significantly more common in the high-dose voclosporin group compared to placebo at 48 weeks. There were more serious adverse events in both voclosporin groups, and more deaths in the low-dose group compared to placebo and high-dose voclosporin groups (11.2%, 1.1%, and 2.3%, respectively). These results suggest that the addition of low-dose voclosporin to mycophenolate mofetil and corticosteroids for induction therapy of active LN results in a superior renal response compared to mycophenolate mofetil and corticosteroids alone, but higher rates of adverse events including death were observed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.kint.2018.08.025

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 309

Metadata

Authors
Rovin, B. H., Solomons, N., Pendergraft, W. F., Dooley, M. A., Tumlin, J., Romero-Diaz, J., Lysenko, L., Navarra, S. V., Huizinga, R. B., Adzerikho, I., Mikhailova, E., Mitkovskaya, N., Pimanov, S., Soroka, N., Bogov, B. I., Deliyska, B., Ikonomov, V., Tilkiyan, E., Almeida, R., Jimenez, F., Teran, F., Tchokhonelidze, I., Tsiskarishvili, N., Herrera Mendez, M., Chavez Perez, N. N., Loaeza, A. R., Gutierrez Urena, S. R., Romero Diaz, J., Araiza Casillas, R., Madero Rovalo, M., Niemczyk, S., Sokalski, A., Wiecek, A., Klinger, M., Bugrova, O. V., Chernykh, T. M., Kameneva, T. R., Lysenko, L. V., Raskina, T. A., ReshEtko, O. V., Vezikova, N. N., Kropotina, T. V., Maksudova, A. N., Marasaev, V., Dobronravov, V. A., Gordeev, I., EssAian, A. M., Frolov, A., Jelacic, R., Jovanovic, D., Mitic, B., Pekovic, G., Radovic, M., Radunovic, G., Carreira, P., Diaz Gonzalez, F., Fulladosa, X., Ucar, E., De Silva, S., Herath, C., Hewageegana, A., Nazar, A. L. M., Wazil, A. W. M., Dudar, I., Godlevska, O., Korneyeva, S., Vasylets, V., Sydor, N., Kolesnyk, M., Parikh, S. V., Olsen, N., Ginzler, E. M., Tumlin, J. A., Saxena, A., Saxena, R., Lafayette, R. A., Pendergraft, W. F., Podoll, A. S., Arrey-Mensah, A. A., Bubb, M., Grossman, J., Oporta, A. I., Nami, A., Rahman, M. M., Haq, S. A., Chan, T. M. D., Temy, M. M. Y., Gomez, H. M. P., Bermas, J., Reyes, B. H., Hao, L. T., Roberto, L. C., Amante, E., Navarra, S. V., Lanzon, A. E., Choe, J.-Y., Kang, T. Y., Kim, Y. S., Lee, S.-G., Lee, J. S., Jun, J. C. C., Vasudevan, A., Luo, S.-F., Cheng, T.-T., Satirapoj, B., & Noppakun, K.
Venue
Kidney International
Publisher
Elsevier BV
Published
2019-01
Volume
95
Issue
1
Pages
219-231
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2900364017
Cited by
309
References
23
FWCI
23.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.